1. Home
  2. RZLT vs ECX Comparison

RZLT vs ECX Comparison

Compare RZLT & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

N/A

Current Price

$4.85

Market Cap

471.0M

Sector

Health Care

ML Signal

N/A

Logo ECARX Holdings Inc. Ordinary shares

ECX

ECARX Holdings Inc. Ordinary shares

N/A

Current Price

$0.84

Market Cap

412.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RZLT
ECX
Founded
2010
2017
Country
United States
United Kingdom
Employees
58
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
471.0M
412.6M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
RZLT
ECX
Price
$4.85
$0.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
★ $9.80
$3.05
AVG Volume (30 Days)
★ 1.7M
959.6K
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.47
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$29.03
Revenue Next Year
$2,481.32
$18.65
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$0.79
52 Week High
$11.46
$2.70

Technical Indicators

Market Signals
Indicator
RZLT
ECX
Relative Strength Index (RSI) 66.61 32.68
Support Level $4.36 N/A
Resistance Level $5.43 $1.14
Average True Range (ATR) 0.31 0.06
MACD 0.11 -0.02
Stochastic Oscillator 93.48 15.86

Price Performance

Historical Comparison
RZLT
ECX

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China. The companies core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: